Patent details
EP0550450 Title: USE OF CROSSLINKED CRYSTALS AS A NOVEL FORM OF ENZYME IMMOBILIZATION
Basic Information
- Publication number:
- EP0550450
- PCT Application Number:
- PCT/US/91/05415
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP919142562
- PCT Publication Number:
- WO/92/00261
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF CROSSLINKED CRYSTALS AS A NOVEL FORM OF ENZYME IMMOBILIZATION
- French Title of Invention:
- EMPLOI DE CRISTAUX RETICULES COMME NOUVELLE FORME D'IMMOBILISATION D'ENZYMES
- German Title of Invention:
- VERWENDUNG VON VERNETZTEN KRISTALLEN ALS NEUEM VERFAHREN ZUR IMMOBILISIERUNG VON ENZYMEN
- SPC Number:
Dates
- Filing date:
- 30/07/1991
- Grant date:
- 14/05/2003
- EP Publication Date:
- 14/05/2003
- PCT Publication Date:
- 20/02/1992
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/07/1993
- EP B1 Publication Date:
- 14/05/2003
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/07/2011
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/04/2003
- Name:
- VERTEX PHARMACEUTICALS INCORPORATED
- Address:
- 130 Waverly Street, Cambridge, MA 02139-4242, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 20/08/2003
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- NAVIA Manuel, A.
- Address:
- United States (US)
2
- Name:
- ST. CLAIR Nancy, L.
- Address:
- United States (US)
Priority
- Priority Number:
- 562280
- Priority Date:
- 03/08/1990
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 11/00;
| Filing date | Document type | Number of pages |
|---|